1] Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia. [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia. [3] Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria 3050, Australia.
Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
Nat Rev Cancer. 2014 Mar;14(3):159-72. doi: 10.1038/nrc3677.
The generation of new lymphatic vessels through lymphangiogenesis and the remodelling of existing lymphatics are thought to be important steps in cancer metastasis. The past decade has been exciting in terms of research into the molecular and cellular biology of lymphatic vessels in cancer, and it has been shown that the molecular control of tumour lymphangiogenesis has similarities to that of tumour angiogenesis. Nevertheless, there are significant mechanistic differences between these biological processes. We are now developing a greater understanding of the specific roles of distinct lymphatic vessel subtypes in cancer, and this provides opportunities to improve diagnostic and therapeutic approaches that aim to restrict the progression of cancer.
新淋巴管的生成(淋巴生成)和现有淋巴管的重塑被认为是癌症转移的重要步骤。过去十年中,癌症淋巴管的分子和细胞生物学研究令人兴奋,并且已经表明肿瘤淋巴管生成的分子控制与肿瘤血管生成有相似之处。然而,这些生物过程在机制上存在显著差异。我们现在对不同类型的淋巴管在癌症中的特定作用有了更深入的了解,这为改善旨在限制癌症进展的诊断和治疗方法提供了机会。